Background: Endometriosis is a common, chronic inflammatory disease which is defined as an overgrowth of endometrial tissue outside the uterine cavity. The etiology of this disease is complex and multifactorial but there is a strong evidence that supports the presence of endometrial stem cells and their possible involvement in endometriosis. Objective: In this study, we analyzed the mRNA expression of REX-1 stemness gene and reconsidered three other stemness genes SOX-2, NANOG, OCT-4 in women with endometriosis compared to normal endometrium. Materials and Methods: Ten ectopic and ten eutopic tissue samples along with 23 normal endometrium specimens were recruited in this study. The expression levels of OCT-4, NANOG, SOX-2, and REX-1 genes were evaluated by the quantitative real-time polymerase chain reaction. Results: The transcription levels of OCT-4, NANOG, and SOX-2 mRNA were significantly increased in ectopic lesions compared with eutopic and control group (p = 0.041, p = 0.035, p = 0.048), although the REX-1 mRNA increase was not significant between endometriosis and control groups. Also, there were differences in the expression level of these genes in normal endometrium during the menstrual cycles (p = 0.031, p = 0.047, p = 0.031). Conclusion: Based on our data, we confirm the dynamic role of stemness genes in proliferation and growth of normal endometrium during the menstrual cycle and conclude that differential expression levels of these genes may contribute to the pathophysiology of endometriosis.
Introduction
Endometriosis is a gynecological disease in which endometrial glands and stromal tissue grow in areas outside the uterus (1) . The multifactorial entity of endometriosis depends on immunologic, hormonal, environmental, and genetic factors.
Extensive investigations in recent years lead our mind to the dynamic role of endometrial stem/progenitor cells in the pathogenesis of endometriosis, in the way that ' embryonic cell rest theory' has been described as one of the hypotheses for the origin of endometriosis (2) .
Based on this theory, many recent studies focused on stemness-related genes, including pluripotency markers such as Sex determining region Y-box 2 (SOX-2), NANOG, and octamerbinding transcription factor 4 (OCT-4) (3-5). SOX-2 regulates different developmental processes via
binding to the minor groove of target DNA and play vital and substantial roles in proliferation, differentiation, and fate determination of specific cells (6) . SOX-2 can form a heterodimer with OCT-4 and regulate self-renewal and pluripotency of embryonic stem cells as well as primordial germ cells (7) . Also, NANOG, a member of homeobox family genes, has key impress in maintaining of pluripotent stem cells in self-renewal and the undifferentiated conditions (8) .
SOX-2 with OCT 4 and NANOG has been found to cooperatively activate and regulate other stem cells-related gene REX-1 (Zfp-42) (9) . REX-1 is known as a pluripotency marker usually found in undifferentiated embryonic stem cells (9) . It has been declared by investigators that the transcription factors of OCT 4, NANOG, SOX-2, and REX-1 are essential elements of self-regulating, and there are strong evidences showing the epigenetic role of these transcription factors in regulation of stem cells (10) (11) (12) (13) . OCT-4, SOX-2, and NANOG can induce expression of each other and are necessary to retain the self-renewing and undifferentiated state of blastocyst inner cell mass and embryonic stem cells (8) . They also implicate in migration and invasion of cancer cells (5, 8) .
On the other hand, OCT-4 and SOX-2 form a heterodimer before binding to certain promoters and ripen functionally each other (14) . Also, NANOG form heterodimer too and make feedback loop to regulate expression of other pluripotency genes (14) (15) (16) (17) . Among the four aforementioned pluripotency transcription factors, there are some studies that show an aberrant level of OCT-4, NANOG, and SOX-2 in endometriotic tissues (3) (4) (5) . However,
REX-1 is not identified exclusively in women with
ovarian endometriosis in previous studies (3) . 
Materials and Methods

Subjects
Twelve endometriosis women (aged between 20-45 yr) and 23 normal women as control group (aged between 20-45 yr) participated in this casecontrol study.
All enrolled endometriosis patients were consulting for infertility and/or pelvic pain without hyperplasia or neoplasia. All endometriosis cases were in stages III or IV of disease, based on the revised classification of American Fertility International Journal of Reproductive BioMedicine Stemness genes in endometriosis Society (18) . Eutopic endometrial biopsies were collected from patients by piple (n = 10). Ectopic endometrial tissues were collected from patients with endometrioma who underwent diagnostic laparoscopy for endometriosis (n = 10) (Table I) .
From the total samples of both eutopic (n = 10) and ectopic (n = 10) endometrial tissues, eight samples were collected from same patients. All the samples were collected through a proliferative phase.
Women of the control group had at least one child by normal gestation with a regular cycle, no evidence of any pathologic uterine disorders and no use of oral contraception or intrauterine device within the last 3 month. Excluding criteria of the control group were endometrial hyperplasia or neoplasia, inflammatory disease or endometriosis in checkup laparoscopy. Endometrial biopsies of this group were obtained during the proliferative phase (n = 12) and secretary phase, (n = 6) through diagnostic laparoscopic surgery (Table I ) and were found not to have endometriosis during surgery.
Also, endometrial biopsies in the menses phase were collected from five healthy volunteer women (Table I) .
After obtaining tissue samples, every sample was divided into small pieces (50-100 mg) and each piece was placed in RNA later solution straightway and stored in -80 ∘ C until RNA extraction. Secretory phase, n = 6) were compared together.
Total RNA extraction and cDNA synthesis
After tissue collection, TRIzol regent was used (Invitrogen, USA) for the extraction of the total RNA from each group according to the manufacturer' s instruction and then total RNA was treated with DNase-I endonuclease (EN0521-Thermo Scientific, Germany). cDNA synthesis was performed using
RevertAid H Minus First Strand cDNA Synthesis Kit (K1632-Thermo Scientific, Germany) according to the manufacturer' s instruction.
Quantitative real-time PCR
mRNA expression levels of candidate genes were quantified by real-time PCR (qRT-PCR) as described before (19) . Briefly, q-PCR reactions were performed in duplicates on a 7500 RealTime PCR System (Applied Biosystems, USA) using SYBR Green master mix (Applied Biosystems, USA), with designed primers for OCT-4, NANOG, SOX-2, REX-1, and GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) as an internal control gene (Table   II) . The specific primers were designed using Primer 
Ethical consideration
Statistical analysis
The results were reported as mean ± SEM. Data were analyzed using One-Way ANOVA followed by Post Hoc Tukey test. The level of p < 0.05 was taken as a statistical significance.
Results
Comparative evaluation of OCT-4, NANOG, SOX-2, and REX-1 expression in control, eutopic, and ectopic tissues
The mean relative expressions of OCT-4, NANOG, and SOX-2 were significantly higher in ectopic endometrium compared with eutopic and normal endometrium (p = 0.041), but the REX-1 mRNA increase was not significant between endometriosis and control groups. The analysis was carried out on the normal endometrium in the proliferative phase (p = 12) and paired eutopic (p = 10) and ectopic endometrium specimens (p = 10) were in the proliferative phase. During this study, parallel to analyzing the endometriotic samples, the expression pattern of the four aforementioned stemness genes was monitored in control endometrium during the menstrual cycle in three phases. Our results showed a significant increase in mRNA levels of OCT-4, SOX-2, and REX-1 in proliferative phase, compared to secretory and menses. About NANOG, also an increased expression was observed in the proliferative phase, although it didn't reach a significant level (p > 0.05). We can easily construe these results with the dynamic role of stemness genes in the proliferation and self-renewal of normal endometrium.
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Discussion
Conclusion
Finally, it can be concluded that the altered expression profile of stemness genes in this study indicates more the fundamental role of them in the expatriation, proliferation, invasion, and overall development of endometriosis.
